You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
嘉應制藥(002198.SZ):聘請西南證券為保薦機構
格隆匯 11-22 17:43

格隆匯11月22日丨嘉應制藥(002198.SZ)公佈,公司於2021年7月6日召開了2021年第三次臨時股東大會,審議通過了關於公司2021年度非公開發行A股股票的相關議案,股東大會同意授權董事會全權辦理本次非公開發行A股股票相關事宜。公司董事會於2021年11月22日召開第六屆董事會第四次臨時會議,審議通過《關於聘請公司2021年度非公開發行A股股票事項的保薦機構的議案》,公司董事會同意聘請西南證券擔任公司本次非公開發行A股股票的承銷及保薦機構並與對方簽署相關協議,同時授權公司總經理朱拉伊為辦理上述事宜的有權簽字人。

西南證券具體負責本次非公開發行A股股票上市的保薦、分銷工作及本次非公開發行A股股票上市後的持續督導工作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account